Results of the use of vitamin A and retionoids in cutaneous malignancies

Pharmacology and Therapeutics

Volumn 40, Issue 1, 1989, Pages 107-122

  Lippman, S M ^a   Meyskens Jr , F L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID DERIVATIVE; RETINOL;

HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN CARCINOMA; SKIN PRECARCINOMA;

ANIMAL; ETRETINATE; HUMAN; ISOTRETINOIN; KERATOSIS; MYCOSIS FUNGOIDES; RETINOIDS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VITAMIN A;

EID: 0024499082     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(89)90078-8     Document Type: Article

References (109)

1. Recent advances in topical cytotoxic therapy of skin cancer and pre-caner
2. Rationale and strategies for chemoprevention of cancer in humans
3. Retinoids and cancer
4. Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology
5. Vitamin A acid in benign and malignant epithelial tumours of the skin
6. Retinoids as inhibitors of tumor promotion
7. Beta-carotene: an unusual type of lipid antioxidant
8. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer and other malignancies
9. Treatment of cutaneous T-cell lymphomas with retinoid
10. Treatment of cutaneous T-cell lymphoma with a new aromatic retinoid (Ro 10-9359)
11. The in vitro characterization of the inhibition of mouse brain kinase-C by retinoids and their receptors
12. Effect of vitamin A on 7,12-dimethylbenz(α) anthracene-induced papillomas in rhino mouse skin: Part 1
13. Vitamin A and the liver
14. Treatment of epidermodyplasia verriformis or multiple verrucae planae by oral aromatic retionoid (Ro 10-9359-Tigason)
15. Retionoids, cancer, and the skin
16. Etretinate therapy
17. Inhibition of the growth and development of a transplantable murine melanoma by vitamin A
18. Immune and toxic antitumor effects of systemic and intralesional vitamin A
19. Treatment of mycosis fungoides with isotretinoin
20. Influence of 13-cis-retinoic acid on mouse skin tumor initiation and promotion
21. Effects of dietary retinyl palmitate of 13-cis-Retinoic acid on the promotion of tumors in mouse skin
22. Phase II trial of retinol in patients with advanced cancers
23. Inhibition of hamster tongue carcinogenesis by selenium and retinoic acid
24. Precursor lesions in familial melanoma
25. Cutaneous neoplasia and etretinate
26. Epidermodysplasia verruciformis (2 cases). Immunological study
27. Treatment of keratoacanthomas with oral 13-cis-retinoic acid
28. Modulation of carcinogenesis in the urinary baldder by retinoids
29. Retionoid-oral photochemotherapy (RePUVA), a combined treatment of mycosis fungoides
30. Chemoprevention of mammary tumorigenesis by a combined regimen of selnium and vitamin A
31. Sur un cas de mycosis fongoide avec manifestations tumorales traite avec Ro 10-9359 (Tigason)
32. Ro 10-9359 in epidermodysplasia verruciformies: preliminary reprot
33. Mycosis fungoides
34. Modulation of cell growth by retionoids and their possible mechanisms of action
35. Action of retinoic acid on the diacylglycerol-induced ornithine decarboxylase activity, reduction of EGF binding and protein kinase C activation in rat tracheal epithelial 2C5 cells
36. Epidermodysplasia verriciformis. Clinical and light- and electron-microscopic observations during etretinate therapy
37. Successful treatment of cutaneous helper T-cell lymphoma (myosis fungoides) with 13-cis-retinoic acid
38. Isotretinoin and cutaneous helper T-cell lymphoma (mycosis fungoides)
39. The effects of a novel potent oral retinoid (Ro 13-6298) in the treatment of multiple solar keratoses and squamous cell epithelioma
40. The effect of dietary zinc and vitamin A on the growth of Morris Hepatoma 7800
41. New aspects of the tolerance of retinol in humans
42. Adjuvant therapy for high risk local and regional melanoma using 13-cis-retinoic acid
43. Effect of topical retinoic acid on intracutaneously implanted S91 melanoma in mice
44. Topical vitamin-A-acid therapy for cutaneous metastatic melanoma
45. Topical vitamin A acid therapy for dysplastic nevi
46. Oral isotretinoin therapy: use in a patient with multiple cutaneous squamous cell carcinomas and keratocanthomas
47. Differential retinoic acid inhibiton of ornithine decarboxylase induction as 12-O-tetradecanoul-phorbol-13-acetate and by germicidal ultraviolet light
48. Treatment of advanced squamous cell carcinoma ofthe skin with Isotretinoin
49. Retinoids as preventive and therapeutic anticancancer agents (Part I)
50. Retinoids as preventive and therapeutic anticancancer agents (Part II)
51. Retinoid acid-induced changes in epidermal growth factor binding and in biological responses mediated by phorbol ester tumor promoter
52. Arotinoids, a new calss of highly active retinoids
53. Inhibition of phorbol ester-induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies
54. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibiton
55. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
56. Immunomodulatory effects of retionoids
57. Inhibitory effects of retinoic acid or retinyl acetate on the growth of untransformed, transformed and tumro cells in vitro
58. Identification and characterization of specific induced by retionoic acid in cell surface glycoconjugates of S91 muring melanoma cells
59. Correlation of retinoic acid-enhanced sialytransferase activity and glycosylation of specific cell surface sialyglycoproteins with growth inhibition in a murine melanoma cell system
60. Oral aromatic retinoid (Ro 10-9359) treatment of two patients suffering with the severe form of epidermodysplasia verruciformis
61. Chemotherapie butaner T-cell-lymphocyte mit arotinoid
62. Dimethylsulfoxide, retinoic acid and 12-O-tetra-decanoulphorbol-13-acetate induced a selective decrease in the phosphorylation of P150, a surface membrane phosphoprotein of HL60 cells resistant to Adriamycin
63. Serum beta-carotene vitamin A and E selenium and the risk of lung cancer
64. Prevention and treatment of cancer with vitamin A and the retinoids
65. Activity of isotretinoin against squamous cell cancers and preneoplastic lesions
66. Role of topical tretinoin in melanoma and dysplastic nevi
67. Randomized trial of BCG ± vitamin A for stages I and II cutaneous malignant melanoma
68. 13-cis-Retinoic acid in mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Group
69. Inhibition of carcinogenesis by retinoids
70. Retionoids and mammary gland differentiation
71. Effect of vitamin A deficiency in animals: pharmacology and toxicology of vitamin A
72. Etretinate in treatment of actinic keratosis: a double blind crossover study
73. No effect of riboflavine, retinol, and zinc on pevalence of precancerous lesions of esophagus. Randomzied double-blind intervention study in high-risk population of China
74. The effect of isotretinoin in six patients with cutaneous T-cell lymphoma
75. Studies and perspectives of protein kinase C
76. Triphenylethylenes: A new class of protein kinase C inhibitors
77. Antitumor potential of retinoic acid: stimulation of immune mediated effectors
78. Retinoids in clinica; dermatology
79. Therapy and prevention of skin cancer
80. Treatment of basal cell carcinoma with 13-cis-retinoic acid
81. Chemoprevention of basal cell carcinoma with isotretinoin
82. Serum retinol and risk of subsequent cancer: extension of the Evans County, Georgia, study
83. Effects of high dietary retinyl palmitate and selenium on tissue distribution of retinoids in mice exposed to tumor initiation and promotion
84. Can dietary beta-carotene materially reduce human cancer rates?
85. Xeroderma pigmentosium: prevention of tumors with etrenate
86. Analysis of dietary associations of vitamin A with cancer
87. Prime esperienze su una nuova associazone terapeutica nel trattamento della micozi fungoide in fase tumorale; retinoidi aromatici + PUVA
88. Treatment of basal cell carcinoma with 13-cis-retinoic acid
89. Vitamin A—saure hyperkeratosen epithelialia tumoren and akne
90. Keratoacanthoma: a review
91. Treatment of multiple keratoacanthomas with oral isotretinoin
92. Treatment of parapsoriasis en plaques and mycosis fungoides with an oral aromatic (RO 10-9359
93. Role of retinoids in differentiation and carcinogenesis
94. Mechanisms of action of retinoids
95. 2+-dependent protein kinase (protein kinase C) system from human leukemic cells
96. Effect of combined selenium and retinyla acetate treatment on mammary carcinogenesis
97. Treatment of cutaneous T-cel lymphoma with the arotinoid Ro 13-6298
98. Vitamin A in animal and human nutrition
99. Etretinate and skin cancer prevention
100. A case of mycosis fungoides treated with etretinate
101. Letter: Isotretinoin in cutaneous T-cell lymphoma
102. Preventive effect of etretinate therapy on multiple actinic keratoses
103. Response of human papilloma-associated disease to retinoids
104. Hypertension detection and follow-up program of serum retinol, retinol-binding protein, total carotenoids, and cancer risk: a summary
105. General clinical toxicology of oral retinoids
106. Tissue changes following deprivation of fat soluble A vitamin
107. Multiple functions of vitamin A
108. Oral retinoid in combination with bleomycin, cyclophophamide, prednisone and transfer factor in mycosis fungoides